Steve Feldman, MD, PhD, of Wake Forest University School of Medicine, discusses various effective treatments for alleviating itch in patients with atopic dermatitis (AD), including dupilumab and Janus ...

Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, ...

Please provide your email address to receive an email when new articles are posted on . Roflumilast cream 0.15% showed rapid itch reduction within 24 hours of first application. More than 40% of ...

The itch won’t quit. So you scratch. Then your skin burns, cracks, and flares. If you have atopic dermatitis (AD), you know the cycle all too well. Maybe you’ve tried steroid creams or other ointments ...

A small study recently found that the experimental drug nemolizumab (Mitchga) substantially improved itching in people with atopic dermatitis (AD). These improvements, in turn, were associated with ...

STAMFORD, Conn., March 28, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of ...

Arcutis Biotherapeutics, Inc., a commercial-stage biopharmaceutical company focused on developing innovations in immuno-dermatology, announced the U.S. Food and Drug Administration has approved the ...

An experimental treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...

Apogee Therapeutics signaled a “best case scenario” on Monday for its experimental eczema treatment, ...

Topical ruxolitinib appears to quickly relieve itch in Black patients with atopic dermatitis (AD), an industry-sponsored analysis of pooled data from two studies suggests. "Ruxolitinib cream ...